ProQR Therapeutics N.V (PRQR) Notes Payables: 2021-2025
Historic Notes Payables for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $5,611.
- ProQR Therapeutics N.V's Notes Payables rose 13.29% to $5,611 in Q3 2025 from the same period last year, while for Sep 2025 it was $5,611, marking a year-over-year increase of 13.29%. This contributed to the annual value of $4,896 for FY2024, which is 5.46% up from last year.
- According to the latest figures from Q3 2025, ProQR Therapeutics N.V's Notes Payables is $5,611, which was up 4.87% from $5,351 recorded in Q2 2025.
- Over the past 5 years, ProQR Therapeutics N.V's Notes Payables peaked at $43.1 million during Q1 2022, and registered a low of $4,618 during Q4 2023.
- Over the past 3 years, ProQR Therapeutics N.V's median Notes Payables value was $4,953 (recorded in 2024), while the average stood at $1.0 million.
- Per our database at Business Quant, ProQR Therapeutics N.V's Notes Payables soared by 216,181.09% in 2022 and then tumbled by 99.89% in 2023.
- ProQR Therapeutics N.V's Notes Payables (Quarterly) stood at $5.5 million in 2021, then decreased by 20.16% to $4.4 million in 2022, then plummeted by 99.89% to $4,618 in 2023, then grew by 6.03% to $4,896 in 2024, then increased by 13.29% to $5,611 in 2025.
- Its Notes Payables was $5,611 in Q3 2025, compared to $5,351 in Q2 2025 and $4,897 in Q1 2025.